China launched a pilot project to improve its rare disease healthcare levels

被引:0
|
作者
Yazhou Cui
Xiaoyan Zhou
Jinxiang Han
机构
[1] Shandong Medical Biotechnological Center,Shandong Academy of Medical Science
[2] Key Laboratory for Biotech Drugs of the Ministry of Health,undefined
关键词
Rare Disease; Clinical Pathway; Orphan Drug; Epidermolysis Bullosa; Hereditary Spastic Paraplegia;
D O I
暂无
中图分类号
学科分类号
摘要
China is facing the great challenge of serving the world’s largest rare disease population. It is necessary to develop a specific medical plan to increase the levels of optimal prevention, diagnosis and treatment of rare diseases under the existing clinical service structures in China. In 2013, China launched its first pilot project focused on 20 representative rare diseases. A national network including approximately 100 provincial or municipal medical centers has been established to enable collaboration on rare diseases across China. The main objectives for this project are to develop and apply medical guidelines and clinical pathways for rare diseases, to establish a rare disease patient registry and data repository system, and to promote molecular testing for rare genetic disorders. This project also emphasizes building close links among the collaborative network, clinicians on the frontlines in basic medical services institutions and rare disease patient organizations. Primarily, this project expects to develop an actionable medical services plan to increase the delivery of quality healthcare for individuals and families living with rare diseases in China within five years.
引用
收藏
相关论文
共 36 条
  • [1] China launched a pilot project to improve its rare disease healthcare levels
    Cui, Yazhou
    Zhou, Xiaoyan
    Han, Jinxiang
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [2] Parkinson's disease registry in Thailand launched: The first pilot project
    Bhidayasiri, R.
    Wannachai, N.
    Limpabandhu, S.
    Asawawichienchinda, T.
    Poolpolamnuay, T.
    Kaewwilai, L.
    Devahastin, R.
    Phanthumchinda, K.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S121 - S122
  • [3] Rare diseases and sports: A pilot project to improve physical activity in patients with mucopolysaccharidosis
    Wittke, Torge-Christian
    Schmidtke, Joerg
    Grigull, Lorenz
    [J]. TRANSLATIONAL SPORTS MEDICINE, 2018, 1 (05) : 184 - 190
  • [4] The definition of rare disease in China and its prospects
    Lu, Yanqin
    Han, Jinxiang
    [J]. INTRACTABLE & RARE DISEASES RESEARCH, 2022, 11 (01) : 29 - 30
  • [5] Rare genetic disease in China: a call to improve clinical services
    Chopra, M.
    Duan, T.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [6] Rare genetic disease in China: a call to improve clinical services
    M. Chopra
    T. Duan
    [J]. Orphanet Journal of Rare Diseases, 10
  • [7] The impact of the 100,000 Genomes Project on rare disease in national healthcare
    Smedley, D.
    Abbs, S.
    Arno, G.
    Baple, E.
    Barnes, M.
    Beales, P.
    Bitner-Glindzicz, M.
    Black, G.
    Brennan, P.
    Chan, G.
    Chinnery, P.
    Cipriani, V.
    Ellard, S.
    Ellingford, J.
    Elliott, P.
    Firth, H.
    Flintner, F.
    Garikano, K. Ibanez
    Houlden, H.
    Irving, M.
    Jacobsen, J.
    McDonagh, E.
    McMullan, D.
    Moutsianas, L.
    Newman, W.
    Ouwehand, W. H.
    Ratnaike, T.
    Martin, A. Rueda
    Penkett, C.
    Raymond, F.
    Sayer, J.
    Scott, R.
    Smith, K.
    Stark, H.
    Stirrups, K.
    Taylor, J.
    Thomas, E.
    Tucci, A.
    Vandrovcova, J.
    Vestito, L.
    Webster, A.
    Wei, W.
    Wielscher, M.
    Williams, H.
    Wilkie, A.
    Wright, C.
    Rendon, A.
    Caulfield, M.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 54 - 55
  • [8] ASSESSING RARE DISEASE REIMBURSEMENT LEVELS AND ECONOMIC BURDEN ON PATIENTS IN CHINA
    Chen, Y.
    Chen, X.
    Deng, Y.
    Yan, J.
    Li, J.
    Ding, J.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S205 - S206
  • [9] Genome-wide Sequencing Ontario (GSO): An implementation pilot to improve rare disease diagnostics
    Marshall, Christian
    Gillespie, Meredith
    Szuto, Anna
    Chisholm, Caitlin
    Stavropoulos, James
    Venkataramanan, Viji
    Tsiplova, Kate
    Price, Magda
    Lau, Lynette
    Khan, Reem
    Lee, Whiwon
    Huang, Lijia
    Jarinova, Olga
    Sawyer, Sarah
    Ungar, Wendy
    Mendoza, Roberto
    Hayeems, Robin
    Somerville, Martin
    Boycott, Kym
    [J]. GENETICS IN MEDICINE, 2022, 24 (03) : S318 - S318
  • [10] Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China
    Xu, Juan
    Yu, Mingren
    Zhang, Zhiguo
    Gong, Shiwei
    Li, Bingqin
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11